Peter Verwaijen
Sales & Marketing chez EGETIS THERAPEUTICS AB
Postes actifs de Peter Verwaijen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| EGETIS THERAPEUTICS AB | Sales & Marketing | 05/05/2022 | - |
Historique de carrière de Peter Verwaijen
Anciens postes connus de Peter Verwaijen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Directeur Financier/CFO | 17/04/2009 | - |
Glaucus Proteomics BV
 Glaucus Proteomics BV Miscellaneous Commercial ServicesCommercial Services Glaucus Proteomics BV develops antibody and protein array technologies to optimize drug development and disease management. The company was founded in 2000 and is headquartered in Utrecht, the Netherlands. | Comptroller/Controller/Auditor | - | - |
Statistiques
Internationale
| Pays-Bas | 3 |
| Suède | 2 |
Opérationnelle
| Comptroller/Controller/Auditor | 1 |
| Director of Finance/CFO | 1 |
| Sales & Marketing | 1 |
Sectorielle
| Health Technology | 3 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| EGETIS THERAPEUTICS AB | Health Technology |
| Entreprise privées | 2 |
|---|---|
Glaucus Proteomics BV
Glaucus Proteomics BV Miscellaneous Commercial ServicesCommercial Services Glaucus Proteomics BV develops antibody and protein array technologies to optimize drug development and disease management. The company was founded in 2000 and is headquartered in Utrecht, the Netherlands. | Commercial Services |
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Health Technology |
- Bourse
- Insiders
- Peter Verwaijen
- Expérience
